LABP - Landos Biopharma Inc.'s (LABP) CEO Tim Mayleben On Q3 2021 Results - Earnings Call Transcript
Landos Biopharma, Inc. (LABP) Q3 2021 Earnings Conference Call November 15, 2021 8:00 A.M. ET Company Participants Becky Mosig - Director of Administration and Operations Chris Garabedian - Chairman of the Board Tim Mayleben - Interim President and Chief Executive Officer Conference Call Participants Chris Howerton - Jefferies Jessica Fye - J.P. Morgan Thomas Smith - SVB Leerink Prakhar Agrawal - Jones Trading Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:07 Welcome to the Landos Biopharma Corporate Update Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to
For further details see:
Landos Biopharma, Inc.'s (LABP) CEO Tim Mayleben On Q3 2021 Results - Earnings Call Transcript